HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vesicular changes in the myopathies of AIDS. Ultrastructural observations and their relationship to zidovudine treatment.

Abstract
Six patients with AIDS and AIDS related complex (ARC) who developed neuromuscular symptoms associated with vesicular changes in muscle fibres are reported. Two patients in the advanced stages of AIDS, who did not receive zidovudine, developed proximal limb weakness and wasting: both had a necrotising myopathy with an unusual segmental vesicular change of myofibres. There were numerous vesicles 0.1 to 2 microns in diameter produced by dilatations of the sarcoplasmic reticulum in fibres depleted of myofibrils. Four patients developed a myopathy while receiving zidovudine for AIDS. One of these had an inflammatory myopathy which showed the development of vesicular change due to enlargement and electron lucency of mitochondria. The three other patients with ARC developed muscle pains or weakness and elevated serum CK while on zidovudine. These patients also showed vesicular changes due to enlargement and electron lucency of mitochondria associated with disruption of sarcomeres and the presence of cytoplasmic bodies. The muscular symptoms resolved when ziduvodine was stopped and repeat biopsy in one case revealed no abnormalities.
AuthorsP K Panegyres, J M Papadimitriou, P N Hollingsworth, J A Armstrong, B A Kakulas
JournalJournal of neurology, neurosurgery, and psychiatry (J Neurol Neurosurg Psychiatry) Vol. 53 Issue 8 Pg. 649-55 (Aug 1990) ISSN: 0022-3050 [Print] England
PMID2170584 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Zidovudine
Topics
  • Acquired Immunodeficiency Syndrome (drug therapy, pathology)
  • Adult
  • Biopsy
  • Cytopathogenic Effect, Viral (physiology)
  • Cytoplasm (ultrastructure)
  • HIV (pathogenicity)
  • Humans
  • Inclusion Bodies (ultrastructure)
  • Male
  • Microscopy, Electron
  • Middle Aged
  • Muscles (pathology)
  • Muscular Atrophy (chemically induced, pathology)
  • Myofibrils (ultrastructure)
  • Necrosis
  • Sarcoplasmic Reticulum (ultrastructure)
  • Zidovudine (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: